Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Molecular Partners Ag ADR (MOLN)

Molecular Partners Ag ADR (MOLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 144,115
  • Shares Outstanding, K 40,375
  • Annual Sales, $ 5,650 K
  • Annual Income, $ -61,390 K
  • EBIT $ -70 M
  • EBITDA $ -67 M
  • 60-Month Beta 1.16
  • Price/Sales 30.03
  • Price/Cash Flow N/A
  • Price/Book 1.05

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.39
  • Growth Rate Est. (year over year) +256,253.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.51 +19.63%
on 04/09/25
4.77 -12.01%
on 03/26/25
+0.32 (+8.22%)
since 03/25/25
3-Month
3.51 +19.63%
on 04/09/25
5.41 -22.38%
on 01/27/25
-1.13 (-21.22%)
since 01/24/25
52-Week
3.51 +19.63%
on 04/09/25
12.70 -66.94%
on 06/20/24
+0.32 (+8.22%)
since 04/22/24

Most Recent Stories

More News
Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025

MOLN : 4.20 (+2.92%)
Molecular Partners Announces all Board Proposals Approved at Annual General Meeting

MOLN : 4.20 (+2.92%)
Molecular Partners to hold three poster presentations at AACR 2025

MOLN : 4.20 (+2.92%)
Molecular Partners Publishes Invitation to Annual General Meeting 2025

MOLN : 4.20 (+2.92%)
Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024

MOLN : 4.20 (+2.92%)
Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call

MOLN : 4.20 (+2.92%)
Molecular Partners and Orano Med expand partnership to develop Targeted Alpha Radio-Therapies for cancer

MOLN : 4.20 (+2.92%)
Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference

MOLN : 4.20 (+2.92%)
Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January

MOLN : 4.20 (+2.92%)
Molecular Partners AG Reports Acceptable Safety Profile and Initial Efficacy Data for MP0533 and MP0621 at ASH 2024

Molecular Partners updates on MP0533 and MP0621 studies, showing acceptable safety and initial efficacy in ongoing clinical trials.Quiver AI SummaryMolecular Partners AG announced continued progress in...

MOLN : 4.20 (+2.92%)

Business Summary

Molecular Partners AG is a clinical-stage biotech company. It involved in developing a new class of custom-built protein drugs known as DARPin(R) therapeutics. Molecular Partners AG is based in SWITZERLAND.

See More

Key Turning Points

3rd Resistance Point 4.48
2nd Resistance Point 4.34
1st Resistance Point 4.27
Last Price 4.20
1st Support Level 4.06
2nd Support Level 3.92
3rd Support Level 3.85

See More

52-Week High 12.70
Fibonacci 61.8% 9.19
Fibonacci 50% 8.10
Fibonacci 38.2% 7.02
Last Price 4.20
52-Week Low 3.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar